Catalyst Wire Dossier Catalyst Wire Dossier

Moderna COVID-19 Bivalent Vaccine (Original/BA.4/BA.5)

mRNA-1273 bivalent vaccine · ModernaTX, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Moderna COVID-19 Bivalent Vaccine (Original/BA.4/BA.5), covering 2024-07-31 to 2024-07-31. Get the full timeline:

Most recent: Clinical Trial Update: An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)

See pricing